IRIS
DI PASQUA, LAURA GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.657
AS - Asia 1.926
EU - Europa 1.422
SA - Sud America 277
AF - Africa 93
OC - Oceania 6
Totale 6.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.589
CN - Cina 743
SG - Singapore 423
IE - Irlanda 414
HK - Hong Kong 262
VN - Vietnam 254
RU - Federazione Russa 247
BR - Brasile 201
DE - Germania 165
FR - Francia 117
IT - Italia 116
FI - Finlandia 112
IN - India 55
GB - Regno Unito 53
ZA - Sudafrica 45
CA - Canada 43
JP - Giappone 33
SE - Svezia 33
UA - Ucraina 31
BD - Bangladesh 30
AR - Argentina 29
BE - Belgio 29
CZ - Repubblica Ceca 28
MX - Messico 22
PL - Polonia 19
EC - Ecuador 18
ID - Indonesia 16
IQ - Iraq 14
PK - Pakistan 13
TR - Turchia 13
ES - Italia 11
CO - Colombia 10
NG - Nigeria 9
PH - Filippine 9
SA - Arabia Saudita 9
MA - Marocco 8
AT - Austria 7
EG - Egitto 7
NL - Olanda 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
MY - Malesia 6
UZ - Uzbekistan 6
IL - Israele 5
JO - Giordania 5
KR - Corea 5
TN - Tunisia 5
BO - Bolivia 4
ET - Etiopia 4
HR - Croazia 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
AU - Australia 3
DZ - Algeria 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CL - Cile 2
GR - Grecia 2
IM - Isola di Man 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CD - Congo 1
CH - Svizzera 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MR - Mauritania 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
RE - Reunion 1
SN - Senegal 1
TM - Turkmenistan 1
Totale 6.381
Salva come PNG Salva come JPEG
Città #
Chandler 455
Dublin 412
San Jose 270
Hong Kong 253
Ashburn 240
Beijing 240
Singapore 211
Dallas 163
Los Angeles 95
Boardman 86
Lauterbourg 82
Helsinki 74
Hanoi 73
Ho Chi Minh City 71
Munich 69
Shanghai 69
Moscow 68
Princeton 65
Lawrence 63
Medford 61
Nanjing 51
New York 51
Jacksonville 49
Wilmington 44
Pavia 41
Ann Arbor 38
Johannesburg 38
Tokyo 33
Redondo Beach 32
Buffalo 31
Brussels 29
Orem 26
Hebei 25
Changsha 22
Turku 22
Brno 21
Milan 21
Nanchang 20
Atlanta 19
São Paulo 19
Hangzhou 18
Montreal 18
Warsaw 18
Da Nang 16
Haiphong 15
The Dalles 15
Tianjin 15
Toronto 15
Brooklyn 14
Chennai 14
Frankfurt am Main 14
Santa Clara 14
Shenyang 14
London 13
Seattle 13
Council Bluffs 12
Houston 12
Mexico City 12
Jiaxing 11
Columbus 10
Düsseldorf 10
Monza 10
San Francisco 10
Chicago 9
Denver 9
Poplar 9
Quito 8
Baghdad 7
Berlin 7
Des Moines 7
Fairfield 7
Falkenstein 7
Falls Church 7
Guayaquil 7
Nuremberg 7
Port Harcourt 7
Thái Nguyên 7
Amsterdam 6
Cagliari 6
Dhaka 6
Guangzhou 6
Paris 6
Rio de Janeiro 6
Ankara 5
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Charlotte 5
Curitiba 5
Hải Dương 5
Lahore 5
Raleigh 5
Redwood City 5
Stockholm 5
Tashkent 5
Washington 5
Amman 4
Brdo 4
Bắc Ninh 4
Campinas 4
Totale 4.287
Salva come PNG Salva come JPEG
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 169
Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress 162
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 140
Metabolic shift in liver: correlation between perfusion temperature and hypoxia inducible factor-1α. 134
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 132
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 128
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 123
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 120
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 114
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 114
Fluorescing fatty acids in rat fatty liver models 113
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 111
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 110
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 110
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 109
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 106
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 104
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 100
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 99
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 98
Fluorescence excitation properties of bilirubin in solution and in serum 98
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 96
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 95
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 92
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 92
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 91
Immobilized amyloid Aβ peptides support platelet adhesion and activation 90
Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion 88
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 88
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 88
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 85
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 85
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 84
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 83
Liver injury and changes in biliary, tissue and serum levels of Asymmetric Dimethylarginine: role of Obeticholic Acid, a Farnesoid X Receptor agonist. 82
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 81
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 80
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 78
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 78
Autofluorescence detection of liver oxidative damage products 78
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 78
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 76
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 76
SerpinB3 administration protects liver against ischemia-reperfusion injury 75
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 73
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 73
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 71
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 69
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 69
Changes in glutathione content in liver diseases: An update 68
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 68
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 68
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 68
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 67
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 67
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 67
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH 66
Rauwolfia vomitoria (Apocynaceae): A comprehensive insight into its botany, ethnomedicinal uses, pharmacology, phytochemistry, and clinical trials 66
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 66
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 66
MPEP administration reduces steatosis and inflammation in ob/ob mice 66
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 63
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 62
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 61
Targeting mitochondrial complex I modulates lipid metabolism, inflammation and hepatic fibrosis in a MCD-diet model of benign steatosis 58
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis 58
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 57
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 56
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats 55
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH 54
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 54
MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats 52
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 51
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 51
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 46
Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management 45
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 40
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 35
Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries 29
Molecular Targets in Liver Disease 9
Totale 6.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 12 9 2
2021/2022325 2 3 4 3 7 6 4 26 5 11 101 153
2022/20231.207 138 112 12 136 59 128 1 58 489 12 49 13
2023/2024480 78 54 23 24 39 83 49 30 1 20 31 48
2024/20251.270 26 86 22 21 20 92 102 38 332 76 157 298
2025/20262.702 203 168 327 313 398 141 552 118 281 201 0 0
Totale 6.527